Being a listed company is losing its lustre in Tokyo

For many businesses, being public is no longer worth the hassle. — Bloomberg

SOME of Japan’s most notable companies are feeling somewhat listless about being listed.

That might be the reason for the US$5bil take-private offer for Taisho Pharmaceutical Co, the largest management buyout in Japanese history, announced last week.